Table 3 ABCG2 and MCM2 expression in tumours with pre operative chemotherapy.

Serial No	Age/sex	Clinicopathological features	Chemotherapy information	% of ABCG2 stained tumour cells	% of MCM2 stained tumour cells	Follow up
1	3y/M	LE: PD, no invasion	4 cycles of triple chemo	40	0	No recurrence in the enucleated eye
2	2y/M	RE: WD, no invasion	2 cycles of triple chemo	60	0
3	2y/M	BE: LE, MD, no invasion	6 cycles of triple chemo	20	0
4	9m/F	RE: PD, no invasion	4 cycles of triple chemo	0	60
5	2y/M	BE: RE, WD, focal Ch invasion	2 cycles of preop chemo, postop 6 cycles triple chemo + TCC + TTT	40	0
6	4m/M	BE: RE, PD, no invasion	2 cycles of triple chemo	50	0

M, male; F, female; y, years; m, months; LE, left eye; RE, right eye; BE, bilateral; PD, poorly differentiated; WD, well differentiated; MD, moderately differentiated; ON, optic nerve; Ch, choroidal; inv, invasion; Chemo, chemotherapy; preop, preoperative; postop, postoperative; TCC, transconjunctival cryopexy.